CIK 1600004
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 40.78% | 15 |
| Health Care Equipment & Supplies | 34.43% | 12 |
| Professional Services | 6.47% | 1 |
| Unclassified | 5.56% | 1 |
| Technology Hardware & Equipment | 4.80% | 2 |
| Software & IT Services | 4.25% | 2 |
| Health Care Providers & Services | 3.72% | 2 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | AXGN | Axogen, Inc. | Health Care | 11.88% |
| 2 | PVLA | PALVELLA THERAPEUTICS, INC. | Health Care | 10.96% |
| 3 | NEO | NEOGENOMICS INC | Industrials | 6.47% |
| 4 | SIBN | SI-BONE, Inc. | Health Care | 6.06% |
| 5 | CENTESSA PHARMACEUTICALS PLC | Unclassified | 5.56% | |
| 6 | APGE | Apogee Therapeutics, Inc. | Health Care | 4.35% |
| 7 | AMLX | Amylyx Pharmaceuticals, Inc. | Health Care | 3.97% |
| 8 | TWST | Twist Bioscience Corp | Health Care | 3.74% |
| 9 | CRNX | Crinetics Pharmaceuticals, Inc. | Health Care | 3.55% |
| 10 | MASS | 908 Devices Inc. | Information Technology | 3.33% |
34/35 names classified · sector 94.4% of weight · industry 94.4% · mkt cap 94.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 94.4% of the book is sector-classified (unclassified names shown, never dropped).
Only 9% of book weight classified — the grid is NOT representative of the whole book.
Classified: 9.3% of book weight (5/35 names) · unclassified 90.7%: AXGN, PVLA, NEO, SIBN, , APGE, AMLX, TWST, CRNX, NPCE +20 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | AXGNAXOGEN INC | 4,002,768 | $133M | 11.9% | TRIM −24% |
| 2 | PVLAPALVELLA THERAPEUTICS INC | 980,758 | $122M | 11.0% | ADD 38% |
| 3 | NEONEOGENOMICS INC | 9,729,978 | $72M | 6.5% | TRIM −3% |
| 4 | SIBNSI-BONE INC | 5,353,190 | $68M | 6.1% | ADD 6% |
| 5 | CENTESSA PHARMACEUTICALS PLC | 1,560,991 | $62M | 5.6% | TRIM −32% |
| 6 | APGEAPOGEE THERAPEUTICS INC | 576,684 | $49M | 4.3% | ADD 102% |
| 7 | AMLXAMYLYX PHARMACEUTICALS INC | 3,190,645 | $44M | 4.0% | TRIM −5% |
| 8 | TWSTTWIST BIOSCIENCE CORP | 878,848 | $42M | 3.7% | TRIM −23% |
| 9 | CRNXCRINETICS PHARMACEUTICALS IN | 1,089,670 | $40M | 3.5% | TRIM −9% |
| 10 | MASS908 DEVICES INC | 6,072,563 | $37M | 3.3% | ADD 26% |
| 11 | NPCENEUROPACE INC | 2,459,966 | $32M | 2.9% | ADD 82% |
| 12 | EWTXEDGEWISE THERAPEUTICS INC | 1,001,846 | $32M | 2.8% | TRIM −36% |
| 13 | ANABANAPTYSBIO INC | 565,431 | $31M | 2.8% | TRIM −13% |
| 14 | SLPSIMULATIONS PLUS INC | 2,632,823 | $31M | 2.8% | ADD 34% |
| 15 | GHGUARDANT HEALTH INC | 280,299 | $26M | 2.3% | TRIM −5% |
| 16 | TNDMTANDEM DIABETES CARE INC | 1,314,715 | $25M | 2.3% | ADD 21% |
| 17 | ATRCATRICURE INC | 729,521 | $21M | 1.9% | TRIM −38% |
| 18 | TLSITRISALUS LIFE SCIENCES INC | 5,066,827 | $20M | 1.8% | NEW |
| 19 | TECXTECTONIC THERAPEUTIC INC | 647,743 | $20M | 1.8% | NEW |
| 20 | IRTCIRHYTHM HOLDINGS INC | 168,116 | $20M | 1.8% | ADD 9% |
| 21 | SEPNSEPTERNA INC | 732,860 | $18M | 1.6% | ADD 18% |
| 22 | ESTAESTABLISHMENT LABS HLDGS INC | 307,738 | $17M | 1.6% | TRIM −18% |
| 23 | HCATHEALTH CATALYST INC | 12,878,700 | $16M | 1.5% | HOLD |
| 24 | OMCLOMNICELL COM | 489,846 | $16M | 1.5% | NEW |
| 25 | KRMDKORU MEDICAL SYSTEMS INC | 3,768,380 | $16M | 1.5% | TRIM −11% |
| 26 | WGSGENEDX HOLDINGS CORP | 242,927 | $16M | 1.4% | NEW |
| 27 | WVEWAVE LIFE SCIENCES LTD | 1,843,968 | $13M | 1.2% | HOLD |
| 28 | VERAVERA THERAPEUTICS INC | 313,906 | $13M | 1.1% | TRIM −64% |
| 29 | MDXGMIMEDX GROUP INC | 2,842,892 | $11M | 1.0% | TRIM −6% |
| 30 | BFLYBUTTERFLY NETWORK INC | 2,660,167 | $11M | 1.0% | TRIM −5% |
| 31 | SGPSPYGLASS PHARMA INC | 375,000 | $10M | 0.9% | NEW |
| 32 | ORGOORGANOGENESIS HLDGS INC | 3,498,533 | $8M | 0.7% | TRIM −9% |
| 33 | PCVXVAXCYTE INC | 141,784 | $8M | 0.7% | NEW |
| 34 | ELVNENLIVEN THERAPEUTICS INC | 201,867 | $8M | 0.7% | NEW |
| 35 | RYTMRHYTHM PHARMACEUTICALS INC | 87,181 | $8M | 0.7% | TRIM −71% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| AXGNAXOGEN INC | 4.5M | 4.5M | 4.5M | 5.8M | 5.2M | 4.0M | $133M |
| PVLAPALVELLA THERAPEUTICS INC | — | — | — | 542K | 709K | 981K | $122M |
| NEONEOGENOMICS INC | 3.2M | 6.0M | 6.8M | 9.9M | 10.0M | 9.7M | $72M |
| SIBNSI-BONE INC | 1.1M | 1.6M | 1.8M | 1.9M | 5.0M | 5.4M | $68M |
| CENTESSA PHARMACEUTICALS PLC | 5.8M | 4.9M | 4.3M | 3.6M | 2.3M | 1.6M | $62M |
| APGEAPOGEE THERAPEUTICS INC | — | — | — | — | 285K | 577K | $49M |
| AMLXAMYLYX PHARMACEUTICALS INC | — | — | — | 3.4M | 3.4M | 3.2M | $44M |
| TWSTTWIST BIOSCIENCE CORP | 1.2M | 1.2M | 945K | 1.2M | 1.1M | 879K | $42M |
| CRNXCRINETICS PHARMACEUTICALS IN | 885K | 855K | 864K | 942K | 1.2M | 1.1M | $40M |
| MASS908 DEVICES INC | — | 1.7M | 1.1M | 2.5M | 4.8M | 6.1M | $37M |
| NPCENEUROPACE INC | — | 1.6M | 1.4M | 1.4M | 1.3M | 2.5M | $32M |
| EWTXEDGEWISE THERAPEUTICS INC | 781K | 1.9M | 1.7M | 1.4M | 1.6M | 1.0M | $32M |
| ANABANAPTYSBIO INC | 869K | 4.6M | 3.5M | 990K | 646K | 565K | $31M |
| SLPSIMULATIONS PLUS INC | — | — | 357K | 768K | 2.0M | 2.6M | $31M |
| GHGUARDANT HEALTH INC | 309K | 271K | 129K | 280K | 295K | 280K | $26M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
